Diabetic Neuropathy in Spinal Cord Stimulator Patients

Part of paid clinical trials in Chicago, Illinois.

Sponsor
University of Chicago
Study ID
NCT04687215
Status
Recruiting
Apply to this trial

Conditions

  • Diabetes Mellitus
  • Microvascular Changes
  • Neuropathic Pain
  • Neuropathy
  • Pain, Chronic
  • Vascular Diseases
  • Vascular Stiffness

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The objective of this study is to assess the effect Spinal Cord Stimulators have toward improving vascular changes of diabetes mellitus in patients eligible for SCS placement based on their condition of painful diabetic neuropathy; we will evaluate improving their disability and quality of life, improving micro-circulatory changes induced by Diabetes Mellitus (DM), improving macro-circulatory changes induced by DM and improving arterial stiffness of the vessels of the lower extremity.

Key Dates

Start date
Jan 27, 2022
Status verified
Feb 2026
Primary completion
Aug 1, 2026
Completion
Dec 1, 2026

Study Design

Enrollment
25 participants (estimated)

Arms

  • Arm: Diabetic patients receiving a spinal cord stimulator
    Patients that have been seen in the diabetic foot clinic will be evaluated for participation in the study once they have been referred to one of our pain clinics.

Primary Outcome Measure

Improve vascular changes [ Time Frame: 6 Weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Chicago Medical CenterChicagoIllinois60637
Magdalena Anitescu, MD, PhD
[email protected]
7738345234
Edward Fox, BA
[email protected]
7738345234

Find similar trials in Chicago, IL

By research site
University of Chicago Medical Center· Chicago, IL

Related Studies